Cutting-edge insights into Helicobacter research.

Area of Science:

• Gastroenterology and Infectious Diseases
• Oncology
• Microbiology

Background:

• Non-Helicobacter pylori Helicobacter (NHPH) species are increasingly recognized as significant gastric pathogens.
• NHPH infections are understudied compared to Helicobacter pylori (H. pylori) due to lower prevalence and diagnostic difficulties.
• Zoonotic transmission of NHPH from animals highlights the need for enhanced clinical awareness and diagnostic tools.

Purpose of the Study:

• To review the clinical significance of NHPH infections.
• To discuss the role of H. pylori in gastric cancer (GC) and the importance of its eradication and post-treatment surveillance.
• To explore emerging diagnostic methods, novel therapeutic strategies for H. pylori, and the molecular mechanisms of gastric carcinogenesis.

Main Methods:

• Literature review focusing on NHPH, H. pylori, gastric cancer, diagnostic techniques, and therapeutic advancements.
• Analysis of current research on zoonotic transmission of NHPH.
• Examination of novel treatment strategies and molecular pathways in gastric carcinogenesis.

Main Results:

• NHPH species pose a growing threat, necessitating improved diagnostics and awareness, especially given zoonotic potential.
• H. pylori remains a primary cause of GC; its eradication is crucial, but antibiotic resistance complicates treatment.
• New therapies (e.g., vonoprazan-based, sitafloxacin, rifabutin) and understanding molecular mechanisms (oxidative stress, cancer stem cells) are vital for improving outcomes.

Conclusions:

• Heightened awareness and improved diagnostics for NHPH are essential.
• Effective H. pylori eradication and post-eradication surveillance are critical for reducing GC incidence.
• Advancements in novel therapies and understanding carcinogenesis mechanisms are key to combating gastric diseases.